>
PICTURED: The 37-year-old who set himself on FIRE outside Trump hush-money trial
Is Speaker Johnson Being BLACKMAILED?
SPEAKER 'RINO' JOHNSON IS A TRAITOR TO THE REPUBLIC THE SAME AS...
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
For the first time, doctors have injected a person with a treatment that will rely on CRISPR gene-editing to treat blindness.
The milestone comes as part of an ongoing clinical trial to evaluate whether the treatment is safe and effective for people with a specific mutation in a single gene; in this case, one that leads to eye disease and vision loss.
CRISPR is a gene-editing tool adapted from the antiviral defense systems of bacteria that can precisely target and cut out short sequences of DNA from longer strands. The technique is being used in ongoing trials to treat cancer and sickle cell anemia by editing human cells outside the body and injecting them into a patient once they've been CRISPR'd; however, this blindness trial is the first that delivers the gene-editing treatment directly into a person's body, NPR reported—specifically, their eye.